MAST3
Summary:
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| microtubule associated serine/threonine kinase 3 | MIM:612258 | Ensembl:ENSG00000099308 | HGNC:HGNC:19036 | PA134877725 | 19p13.11 |
GO terms in MAST3
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| BP | IBA | GO:0007010 | cytoskeleton organization |
| BP | IBA | GO:0018105 | peptidyl-serine phosphorylation |
| BP | IBA | GO:0035556 | intracellular signal transduction |
| MF | IEA | GO:0000287 | magnesium ion binding |
| MF | IBA | GO:0004674 | protein serine/threonine kinase activity |
| MF | IPI | GO:0005515 | protein binding |
| MF | IEA | GO:0005524 | ATP binding |
Gene expression in normal tissue: MAST3
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in MAST3
| Database | Pathway ID | Pathway Des. |
|---|
Gene-Drug: Aster Plot
| Drug ID | Drug Name | Model Num. |
|---|---|---|
| iGMDRD494 | Neopeltolide | 3 |
| iGMDRD226 | ML006 | 3 |
| iGMDRD318 | PAC-1 | 6 |
| iGMDRD870 | BRD63610 | 3 |
| iGMDRD271 | Brefeldin A | 2 |
| iGMDRD554 | CHEMBL1434137 | 2 |
| iGMDRD255 | SB225002 | 3 |
| iGMDRD300 | Tozasertib | 1 |
| iGMDRD268 | Cerulenin | 2 |
| iGMDRD367 | Ro 28-1675 | 2 |
| iGMDRD399 | Selumetinib | 3 |
| iGMDRD57 | Chloropentafluorobenzene | 2 |
Gene in drug-gene network: Network Plot

Gene-drug targets distribution
Gene Structure: PDB
Models in MAST3

